These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study. Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary embolism. McRae S Aust Fam Physician; 2010 Jul; 39(7):462-6. PubMed ID: 20628658 [TBL] [Abstract][Full Text] [Related]
32. Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing. Becattini C; Franco L; Agnelli G Semin Respir Crit Care Med; 2017 Feb; 38(1):94-106. PubMed ID: 28208203 [TBL] [Abstract][Full Text] [Related]
33. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities. Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221 [TBL] [Abstract][Full Text] [Related]
34. [The optimal duration of anticoagulant treatment following pulmonary embolism]. Couturaud F Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935 [TBL] [Abstract][Full Text] [Related]
38. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests. Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194 [TBL] [Abstract][Full Text] [Related]
39. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study. Wan T; Rodger M; Zeng W; Robin P; Righini M; Kovacs MJ; Tan M; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther M; White RH; Vickars L; Bazarjani S; Le Gal G Thromb Res; 2018 Feb; 162():104-109. PubMed ID: 29224973 [TBL] [Abstract][Full Text] [Related]
40. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. Büller HR; Gallus AS; Pillion G; Prins MH; Raskob GE; Lancet; 2012 Jan; 379(9811):123-9. PubMed ID: 22130488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]